View Document Preview and Link Document Date: 2014-09-18 14:06:24 Open Document File Size: 964,39 KB Share Result on Facebook
Company HC0102 Pharmaceuticals / World Bank LIC / World Bank Low-Income / / Event Environmental Issue / / Facility Hospital Readmissions Reduction Program / / IndustryTerm greenhouse gas emissions / Healthcare-acquired infections / supply chain / energy consumption / healthcare professionals / non-renewable energy / counterfeit products / manufacturing practices / healthcare products / authorized generic product / active pharmaceutical product / manufacturing / renewable energy / renewable energy consumption / pharmaceutical products / obesity prevention / Orphan Drugs Social Capital Chronic Disease Prevention / / MedicalCondition pneumonia / employee infection / drugs targeting obesity / disease / malaria / seizure / central line-associated bloodstream infections / vector-borne tropical diseases / high cholesterol / Healthcare-acquired infections / recordable injuries / heart failure / product seizure / infection / urinary tract infections / chronic / non-communicable diseases / high blood pressure / surgical site infections / orphan diseases / Extremely High Baseline Water Stress / acute myocardial infarction / at preventing chronic / non-communicable diseases / / MedicalTreatment catheter / / Organization US Department of Health and Human Services / World Health Organization / World Bank / Sustainability Accounting Standards Board / United Nations / FDA / Occupational Safety and Health Administration / Medicare / / Position Official / nurse / physician / Clinical Investigator / / Technology Biotechnology / API / ATM / / URL www.sasb.org/sustainability‐standards/public‐comment / / SocialTag 
Public Exposure Draft for the sole purpose of SASB’s 30-Day Public Comment Period The contents of this public exposure draft are copyright of the Sustainability Accounting Standards Board (SASB), 2013.